Contribute Try STAT+ Today

Widely embraced as a medical lifeboat during the pandemic, telehealth is showing signs of taking on water.

A new study from a team of Johns Hopkins and Stanford researchers suggests that telemedicine — at least in its current form — may be ill-suited to staunch the collateral health effects of the pandemic, such as a rise in heart attacks and strokes among patients with chronic conditions. The research, published this month in JAMA Network Open, offers an early insight into the quality of telehealth visits during the pandemic at a time when most studies have only looked at quantity.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.